Revance Therapeutics Accounts Receivable (Quarterly) Analysis

Revance Therapeutics Inc (RVNC)

2.75 +0.05 (+1.85%) USD | NASDAQ | Jun 10, 16:00

2.75 0.00 (0.00%) After-Hours: 17:37

Accounts Receivable (Quarterly) Chart

Historical Accounts Receivable (Quarterly) Data

View and export this data back to 2012. Upgrade now.

Date	Value
March 31, 2024	29.89M
December 31, 2023	27.68M
September 30, 2023	25.41M
June 30, 2023	17.04M
March 31, 2023	15.37M
December 31, 2022	11.34M
September 30, 2022	11.73M
June 30, 2022	5.59M
March 31, 2022	4.471M
December 31, 2021	3.348M
September 30, 2021	1.658M
June 30, 2021	0.641M
March 31, 2021	5.186M
December 31, 2020	1.829M
September 30, 2020	2.585M
June 30, 2020	0.049M
March 31, 2020
December 31, 2019	0.00
September 30, 2019	5.00M
June 30, 2019	0.00
March 31, 2019	0.00
December 31, 2018	27.00M

Date	Value
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017	0.048M
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016	0.128M
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015	0.075M
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014	0.30M
September 30, 2014	1.421M
June 30, 2014	0.188M
March 31, 2014	1.786M
December 31, 2013	0.225M
September 30, 2013
December 31, 2012	0.075M

Accounts Receivable Definition

Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.

Read full definition.

Accounts Receivable (Quarterly) Range, Past 5 Years

Minimum

Jun 2019

29.89M

Maximum

Mar 2024

8.885M

Average

5.00M

Median

Sep 2019

Accounts Receivable (Quarterly) Benchmarks